GSK Positions To Dominate In Vaccines; Will The Bet Pay Off?
The British pharma outlined its strategy for winning as one of the world’s leading vaccines makers May 6, two months after completing the acquisition of Novartis’ vaccines business.
The British pharma outlined its strategy for winning as one of the world’s leading vaccines makers May 6, two months after completing the acquisition of Novartis’ vaccines business.